Advertisement
Research Article| Volume 171, ISSUE 2, P362-367, December 2013

Association of GSTP1 −313A/G polymorphisms and endometriosis risk: a meta-analysis of case–control studies

  • Author Footnotes
    1 These authors contributed equally to this work so that they should be considered as the co-first author.
    Xu Chen
    Footnotes
    1 These authors contributed equally to this work so that they should be considered as the co-first author.
    Affiliations
    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work so that they should be considered as the co-first author.
    Yulan Yan
    Footnotes
    1 These authors contributed equally to this work so that they should be considered as the co-first author.
    Affiliations
    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China
    Search for articles by this author
  • Ping Li
    Affiliations
    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China
    Search for articles by this author
  • Zheng Yang
    Affiliations
    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China
    Search for articles by this author
  • Lingyan Qin
    Affiliations
    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China
    Search for articles by this author
  • Wuning Mo
    Correspondence
    Corresponding author at: Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, 22 Shuangyong Road, Nanning 530021, People's Republic of China. Tel.: +86 13878801998.
    Affiliations
    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work so that they should be considered as the co-first author.
Published:October 16, 2013DOI:https://doi.org/10.1016/j.ejogrb.2013.10.005

      Abstract

      Objectives

      In view of the controversies surrounding the association of glutathione S-transferases (GST) P1 with endometriosis, a meta-analysis of GSTP1 −313A/G polymorphism with endometriosis risk was performed.

      Study design

      The relevant studies were identified through a search of PubMed, Excerpta Medica Database (Embase), Elsevier Science Direct and Chinese Biomedical Literature Database (CBM) until March 2013. The association between GSTP1 −313A/G polymorphism and endometriosis risk was pooled by odds ratios (ORs) together with their 95% confidence intervals (95% CIs).

      Results

      A total of eight case–control studies were eventually identified. We found that GSTP1-313A/G polymorphism was not associated with endometriosis risk in the overall population (A vs. G: OR = 1.02, 95% CI = 0.97–1.07, P = 0.511; AA vs. GG: OR = 1.02, 95% CI = 0.98–1.06, P = 0.359; GA vs. GG: OR = 1.03, 95% CI = 0.98–1.08, P = 0.299; AA vs. GA/GG: OR = 1.01, 95% CI = 0.96–1.07, P = 0.621; AA/GA vs. GG: OR = 1.00, 95% CI = 0.97–1.03, P = 0.972). In the sub-group analysis based on ethnicity, a significant association was found in Caucasians under the recessive model (AA vs. GA/GG: OR = 1.28, 95% CI = 1.08–1.53, P = 0.006).

      Conclusions

      GSTP1 −313A/G polymorphism may not be associated with endometriosis risk, while the observed increase in risk of endometriosis may be due to small-study bias. Considering the limited sample size and ethnicity included in our meta-analysis, an updated meta-analysis will be urgently needed when further larger and well-designed studies are published.

      Keywords

      1. Introduction

      Endometriosis is a common inflammatory disease that is characterized by the presence of endometrial tissue outside the uterine cavity. In industrialized countries, the incidence of endometriosis has been reported to be 6–10% of the general female population, and the frequency is 35–50% in women with pain or infertility [
      • Giudice L.C.
      • Kao L.C.
      Endometriosis.
      ]. Women's quality of life is influenced negatively by the pain, infertility and economic burden of the disease but the exact etiology of endometriosis remains unclear.
      Several hypotheses have been raised to explain the origin of endometriosis. Of these, retrograde menstruation is the most widely accepted theory, but still fails to explain the etiopathogenesis of this disease considering the high prevalence of this event (90%), suggesting the involvement of additional genetic or non-genetic risk factors [
      • Halme J.
      • Hammond M.G.
      • Hulka J.F.
      • Raj S.G.
      • Talbert L.M.
      Retrograde menstruation in healthy women and in patients with endometriosis.
      ].
      A great deal of evidence has indicated that endometriosis is likely to be a multifactorial disease. Several factors such as immunologic, hormonal, environmental, and genetic factors may confer susceptibility to endometriosis [
      • Giudice L.C.
      • Kao L.C.
      Endometriosis.
      ,
      • Rier S.E.
      Environmental immune disruption: a comorbidity factor for reproduction?.
      ]. It has been reported that the first-degree relatives of women with endometriosis tend to have a 5–8-fold increase in risk of occurrence of this disease [
      • Bischoff F.
      • Simpson J.L.
      Genetic basis of endometriosis.
      ]. About a 7-fold higher incidence was seen in relatives of women with endometriosis compared with women without a family history [
      • Simpson J.L.
      • Elias S.
      • Malinak L.R.
      • Buttram Jr., V.C.
      Heritable aspects of endometriosis. I. Genetic studies.
      ,
      • Matalliotakis I.M.
      • Arici A.
      • Cakmak H.
      • Goumenou A.G.
      • Koumantakis G.
      • Mahutte N.G.
      Familial aggregation of endometriosis in the Yale Series.
      ]. All these studies support the view that genetic factors and heritable tendencies play an important role in the development of endometriosis.
      Because dioxins (dioxin and dioxin-like chemicals) have an adverse impact on growth factors, cytokines, hormones and the immune system, exposure to dioxins has been proposed to lead to the development of endometriosis. Thus, polymorphisms of the detoxification enzymes which cause a lack of function or decreased function of these enzymes may contribute to endometriosis. Like other members of the glutathione-s-transferase (GST) family, GSTP1, which locates at 11q13, participates in the detoxification of electrophilic compounds by glutathione conjugation [
      • Autrup H.
      Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.
      ]. Both exon 5 and exon 6 are related to the polymorphism and result in amino acid substitutions, but only exon 5 is linked to enzymatic activity. The polymorphism of exon 5 happens at the −313 site, where an adenosine-to-guanidine (A–G) transition leads to an Ile-to-Val substitution.
      It has been confirmed that different GSTs have different conversion efficiency and enantio-selectivity for various toxic products [
      • Hu X.
      • Benson P.J.
      • Srivastava S.K.
      • et al.
      Glutathione S-transferases of female A/J mouse liver and fore stomach and their different induction by anticarcinogenic organosulfides from garlic.
      ,
      • Hu X.
      • Srivastava S.K.
      • Xia H.
      • Awasthi Y.C.
      • Singh S.V.
      An alpha class mouse glutathione S-transferase with exceptional catalytic efficiency in the conjugation of glutathione with 7b, 8a-dihydroxy-9a, 10a-oxy-7,8,9,10-tetrahydrobenzo[a] pyrene.
      ]. A number of studies have reported on the association of GSTM1 and GSTT1 with endometriosis, but studies on the association between GSTP1 and the endometriosis are rare. Furthermore, it has been reported that GSTP1 is a key substance which plays an important role in biotransformation of certain environmental pollutants [
      • Harries L.W.
      • Stubbins M.J.
      • Forman D.
      • Howard G.C.
      • Wolf C.R.
      Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer.
      ]. This suggests that GSTP1 may be more important than other GST in the pathogenesis of endometriosis.
      For this reason, several molecular epidemiological studies have been conducted to evaluate the association of GSTP1 −313A/G polymorphism with endometriosis risk, but the previous results remain controversial rather than consistent [
      • Wang Y.F.
      • Zong L.L.
      • Mao T.
      • et al.
      Relationship of polymorphisms of AhR-1661G/A with GSTP1-313A/G and susceptibility to endometriosis.
      ,
      • Matsuzaka Y.
      • Kikuti Y.Y.
      • Goya K.
      • et al.
      Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study.
      ,
      • Vichi S.
      • Medda E.
      • Ingelido A.M.
      • et al.
      Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene–environment interaction.
      ,
      • Wu C.H.
      • Guo C.Y.
      • Yang J.G.
      • et al.
      Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population.
      ,
      • Jeon M.J.
      • Choi Y.M.
      • Hong M.A.
      • et al.
      No association between the GSTP1 exon 5 polymorphism and susceptibility to advanced stage endometriosis in the Korean population.
      ,
      • Parveen F.
      • Faridi R.M.
      • Das V.
      • Tripathi G.
      • Agrawal S.
      Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.
      ,
      • Ertunc D.
      • Aban M.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
      ,
      • Hur S.E.
      • Lee J.Y.
      • Moon H.S.
      • Chung H.W.
      Polymorphisms of the genes encoding the GSTM1 GSTT1 and GSTP1 in Korean women: no association with endometriosis.
      ]. Therefore, the aim of our study is to derive a more precise estimation of the association between GSTP1 −313A/G polymorphism and endometriosis risk by performing a meta-analysis of all eligible case–control studies. The present research may have clinical impact if we could demonstrate that the GSTP1 −313A/G polymorphism is significantly linked to endometriosis risk. Such a breakthrough may provide the introduction of predictive tests or preventive measures and even support the use of anti-oxidants in the medical treatment of endometriosis.

      2. Materials and methods

      2.1 Search strategy

      We conducted an extensive search for studies that examined the association between the GSTP1 −313A/G polymorphisms and endometriosis risk. All eligible studies were identified by searching the PubMed, Embase, Elsevier Science Direct and Chinese Biomedical Literature Database (CBM) on March 20, 2013 using the terms as follows: (“GSTP1” or “glutathione-s-transferase P1”) in combination with (“polymorphism” or “polymorphisms” or “variant” or “mutation”) in combination with (“endometriosis”) for all publications on the association between GSTP1 −313A/G polymorphisms and endometriosis risk. No language or country restrictions were applied. Additional studies were identified by a hand search of the references of original studies. Review articles were also examined to find additional eligible studies.

      2.2 Inclusion and exclusion criteria

      The following inclusion criteria were applied for selecting papers: (a) the paper must be a case–control study; (b) articles evaluating the association between the GSTP1 polymorphisms and endometriosis risk; (c) the paper had to provide sufficient data to estimate an odds ratio (OR) and 95% confidence interval (95% CI). The following exclusion criteria were applied for excluding papers: (a) review articles and studies that contained overlapping data; (b) case reports; (c) if more than one study from the same group occurred, we only recruited the later study.

      2.3 Data extraction

      From each eligible study, the following information was extracted by two investigators independently with the standard protocol: the name of first author, year of publication, country of origin, ethnicity of the population, the sample size of cases and controls, source of the control group, genotyping methods and allele and genotype distribution in cases and controls. Different ethnicities of the population were categorized as Caucasians, Asian, African or Mixed. The results were reviewed by a third investigator and disagreement was resolved by discussion.

      2.4 Statistical analysis

      The possible association between GSTP1 313A/G polymorphisms and endometriosis risk was evaluated by OR and 95% CI under allele contrast (A vs. G), homozygote (AA vs. GG), heterozygote (GA vs. GG), recessive (AA vs. GA/GG), and dominant (AA/GA vs. GG) models. The heterogeneity between the studies was assessed by Q-statistic. If P < 0.10, between-study heterogeneity was considered to exist, and thus the random-effects model was used (DerSimonian and Laird method) [
      • DerSimonian R.
      • Laird N.
      Meta-analysis in clinical trials.
      ]. Otherwise, the fixed-effects model (the Mantel-Haenszel method) was used to pool the data [
      • Mantel N.
      • Haenszel W.
      Statistical aspects of the analysis of data from retrospective studies of disease.
      ]. In addition, we also quantified the effect of heterogeneity using I2 [
      • Higgins J.P.
      • Thompson S.G.
      Quantifying heterogeneity in a meta-analysis.
      ]. The overall estimate of risk was calculated by the random-effects model when obvious heterogeneity existed (I2 value >50% or P < 0.10). Otherwise, the fixed-effects model was used when obvious heterogeneity was absent (I2 value <50% or P > 0.10). To explore sources of between-study heterogeneity, we did logistic meta-regression analyses. We examined the following study characteristics: ethnicity, source of control and study sample size.
      Sensitivity analysis was used to assess the stability of the pooled studies by sequential omission of individual studies. The sensitivity analysis was also conducted if Hardy–Weinberg equilibrium (HWE) disequilibrium existed (P < 0.05 was considered statistically significant). HWE was tested using a professional web-based program (http://ihg2.helmholtz-muenchen.de/cgibin/hw/hwa1.pl). The funnel plot was used to visually observe the possible publication bias [
      • Munafo M.R.
      • Clark T.G.
      • Flint J.
      Assessing publication bias in genetic association studies: evidence from a recent meta-analysis.
      ]. Begg's and Egger's tests were also used to statistically detect the publication bias (P < 0.05 was considered representative of statistically significant publication bias). STATA Software (version 9.0, Stata Corp) was applied to calculate all the available data for our meta-analysis.

      3. Results

      3.1 Study characteristics

      According to the search criteria, a total of nine publications met our inclusion criteria. Of these articles, one [
      • Aban M.
      • Ertunc D.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Modulating interaction of glutathione-S-transferase polymorphisms with smoking in endometriosis.
      ] was excluded because it only investigated GSTM1 and GSTT1 polymorphism with endometriosis risk. As a result, a total of eight studies were used for our meta-analysis [
      • Wang Y.F.
      • Zong L.L.
      • Mao T.
      • et al.
      Relationship of polymorphisms of AhR-1661G/A with GSTP1-313A/G and susceptibility to endometriosis.
      ,
      • Matsuzaka Y.
      • Kikuti Y.Y.
      • Goya K.
      • et al.
      Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study.
      ,
      • Vichi S.
      • Medda E.
      • Ingelido A.M.
      • et al.
      Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene–environment interaction.
      ,
      • Wu C.H.
      • Guo C.Y.
      • Yang J.G.
      • et al.
      Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population.
      ,
      • Jeon M.J.
      • Choi Y.M.
      • Hong M.A.
      • et al.
      No association between the GSTP1 exon 5 polymorphism and susceptibility to advanced stage endometriosis in the Korean population.
      ,
      • Parveen F.
      • Faridi R.M.
      • Das V.
      • Tripathi G.
      • Agrawal S.
      Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.
      ,
      • Ertunc D.
      • Aban M.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
      ,
      • Hur S.E.
      • Lee J.Y.
      • Moon H.S.
      • Chung H.W.
      Polymorphisms of the genes encoding the GSTM1 GSTT1 and GSTP1 in Korean women: no association with endometriosis.
      ]. The study characteristics of the included studies were presented in Table 1. In total, the eight case–control studies that examined the association between GSTP1 −313A/G polymorphism and endometriosis risk consisted of 1638 endometriosis patients and 1842 controls. There were six studies of Asians [
      • Wang Y.F.
      • Zong L.L.
      • Mao T.
      • et al.
      Relationship of polymorphisms of AhR-1661G/A with GSTP1-313A/G and susceptibility to endometriosis.
      ,
      • Matsuzaka Y.
      • Kikuti Y.Y.
      • Goya K.
      • et al.
      Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study.
      ,
      • Wu C.H.
      • Guo C.Y.
      • Yang J.G.
      • et al.
      Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population.
      ,
      • Jeon M.J.
      • Choi Y.M.
      • Hong M.A.
      • et al.
      No association between the GSTP1 exon 5 polymorphism and susceptibility to advanced stage endometriosis in the Korean population.
      ,
      • Parveen F.
      • Faridi R.M.
      • Das V.
      • Tripathi G.
      • Agrawal S.
      Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.
      ,
      • Hur S.E.
      • Lee J.Y.
      • Moon H.S.
      • Chung H.W.
      Polymorphisms of the genes encoding the GSTM1 GSTT1 and GSTP1 in Korean women: no association with endometriosis.
      ] and two studies of Caucasians [
      • Vichi S.
      • Medda E.
      • Ingelido A.M.
      • et al.
      Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene–environment interaction.
      ,
      • Ertunc D.
      • Aban M.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
      ]. The genotype distribution in the controls of all the studies included in our meta-analysis was consistent with HWE (P > 0.05).
      Table 1General characteristics of studies included in the meta-analysis.
      First authorYearCountryEthnicityMethod of genotypingSource of controlSample size (case/control)HWE of controls
      Wang2012ChinaAsiaPCR-HRMHB432/4930.256
      Matsuzaka2012JapanAsiaDirect SequencingHB100/1430.126
      Vichi2012ItalyCaucasiansPCR-RFLPPB181/1620.482
      Wu2011TaiwanAsiaTaqManHB121/1710.348
      Jeon2009South KoreaAsiaTaqManHB260/1640.661
      Parveen2010IndiaAsiaPCR-RFLPPB200/3000.173
      Ertunc2005TurkeyCaucasiansPCR-HRMPB150/1500.680
      Hur2004South KoreaAsiaPCR-RFLPHB194/2590.110
      PCR-HRM, fluorescent quantitative PCR-based high resolution melting; PCR-RFLP, PCR-restriction fragment length polymorphism; HWE, Hardy–Weinberg equilibrium; HB, hospital based; and PB, population based.

      3.2 Quantitative synthesis of data

      Table 2 lists the main results of our meta-analysis. We found that GSTP1 −313A/G polymorphism was not associated with endometriosis risk in the overall population (A vs. G: OR = 1.02, 95% CI = 0.97–1.07, P = 0.482, Fig. 1 for A vs. G; AA vs. GG: OR = 1.02, 95% CI = 0.98–1.07, P = 0.299, Fig. 2 for AA vs. GG; GA vs. GG: OR = 1.04, 95% CI = 0.98–1.10, P = 0.249; Fig. 3 for GA vs. GG; AA vs. GA/GG: OR = 1.01, 95% CI = 0.96–1.07, P = 0.621, Fig. 4 for AA vs. GA/GG; AA/GA vs. GG: OR = 1.01, 95% CI = 0.99–1.04, P = 0.276; Fig. 5 for AA/GA vs. GG).
      Table 2Results of meta-analysis for GSTP1 −313 A/G polymorphism and endometriosis risk.
      ComparisonPopulationNSample sizeTest of associationModeTest of heterogeneity
      CaseControlOR95% CIPχ2PI2
      A vs. GOverall8327636641.020.97–1.070.482R24.950.00171.9
      Asian6261430400.980.96–1.010.182F7.510.18633.4
      Caucasians26626241.140.97–1.340.115R4.590.03278.2
      AA vs. GGOverall8105512081.020.98–1.070.299R21.620.00367.6
      Asian686810471.000.98–1.020.981F1.820.8740
      Caucasians21871611.190.89–1.570.237R7.840.00587.2
      GA vs. GGOverall86607451.040.98–1.100.249R13.960.05249.9
      Asian64955551.010.96–1.050.721F0.380.9960
      Caucasians21651901.110.85–1.440.434R8.310.00488.0
      AA vs. GA/GGOverall8163818421.010.96–1.070.621R14.800.03952.7
      Asian6130715300.970.92–1.030.295F4.760.4460
      Caucasians23313121.281.081.530.006F1.510.22033.6
      AA/GA vs. GGOverall8163818421.010.99–1.040.276R18.530.01062.2
      Asian6130715301.000.99–1.020.878F1.250.9400
      Caucasians23313121.080.93–1.240.317R8.180.00487.8
      OR, odds ratio; CI, confidence interval; F, fixed effects model; and R, random effects model.
      Figure thumbnail gr1
      Fig. 1Meta-analysis under allelic model for the association between GSTP1 −313A/G polymorphism and endometriosis risk (A vs. G).
      Figure thumbnail gr2
      Fig. 2Meta-analysis under homozygote model for the association between GSTP1 −313A/G polymorphism and endometriosis risk (AA vs. GG).
      Figure thumbnail gr3
      Fig. 3Meta-analysis under heterozygote model for the association between GSTP1 −313A/G polymorphism and endometriosis risk (GA vs. GG).
      Figure thumbnail gr4
      Fig. 4Meta-analysis under recessive model for the association between GSTP1 −313A/G polymorphism and endometriosis risk (AA vs. GA/GG).
      Figure thumbnail gr5
      Fig. 5Meta-analysis under dominant model for the association between GSTP1 −313A/G polymorphism and endometriosis risk (AA/GA vs. GG).
      In the sub-group analysis according to ethnicity, our meta-analysis suggested that GSTP1 A/G polymorphism was not associated with endometriosis risk in the Asian population (Table 2). Interestingly, a significant association was found in Caucasians under recessive model (AA vs. GA/GG: OR = 1.28, 95% CI = 1.08–1.53, P = 0.006, Fig. 4 and Table 2).

      3.3 Heterogeneity analysis and sensitivity analysis

      There was significant heterogeneity for all the genetic models in the overall population. To explore the source of heterogeneity, we assessed the dominant model (AA/GA vs. GG) by ethnicity (Asian or Caucasian), source of control (population-based or hospital-based) and sample size (≤400 subjects or >400 subjects). As a result, ethnicity (P = 0.007) but not source of control (P > 0.05) or sample size (P > 0.05) was found to contribute to substantial heterogeneity. However, some heterogeneity still existed in the Caucasian population and none of these variables could explain the heterogeneity (P > 0.05). Sensitivity analysis was used to assess the stability of pooled studies by sequential omission of individual studies. In our meta-analysis, no single study influenced the overall results qualitatively as indicated by sensitivity analysis. This indicates the robustness and reliability of our results.

      3.4 Publication bias

      Funnel plot and Begg's and Egger's tests were used to assess the publication bias of our included studies. The shape of the funnel plot did not suggest any evidence of obvious asymmetry (figures not shown). Begg's and Egger's tests were used to provide statistical evidence of symmetry. Similarly, the results revealed the absence of publication bias (allelic model: Begg's test P = 0.174, Egger's Test P = 0.057; homozygote model: Begg's test P = 0.108, Egger's Test P = 0.105; heterozygote model: Begg's test P = 0.536, Egger's Test P = 0.660; recessive model: Begg's test P = 0.060, Egger's test P = 0.174; dominant model: Begg's test P = 0.174, Egger's test P = 0.197).

      4. Comments

      Extensive epidemiological, experimental, and molecular evidence indicates that several factors such as immunologic, hormonal and environmental factors play an important role in the development of endometriosis. Since dioxins (dioxin and dioxin-like chemicals) have a negative effect on growth factors, cytokines, hormones and the immune system, exposure to dioxins has been considered to lead to the development of endometriosis. The role of dioxins which leads to endometriosis is neither directly damaging the cells nor combining complexes with proteins and nucleic acids but acting on the target genes in the cell nucleus through integrating with arylhydrocarbon nuclear translocator (ARNT). The GST gene is one of the target genes which regulate human metabolism, immune, endocrine and are closely related with the occurrence of endometriosis.
      It has been confirmed that different GST have different conversion efficiency and enantio-selectivity for various toxic products which may lead to cancer [
      • Hu X.
      • Benson P.J.
      • Srivastava S.K.
      • et al.
      Glutathione S-transferases of female A/J mouse liver and fore stomach and their different induction by anticarcinogenic organosulfides from garlic.
      ,
      • Hu X.
      • Srivastava S.K.
      • Xia H.
      • Awasthi Y.C.
      • Singh S.V.
      An alpha class mouse glutathione S-transferase with exceptional catalytic efficiency in the conjugation of glutathione with 7b, 8a-dihydroxy-9a, 10a-oxy-7,8,9,10-tetrahydrobenzo[a] pyrene.
      ]. GSTP1 is the most important member of GST family which participates in the detoxification of electrophilic compounds by glutathione conjugation [
      • Autrup H.
      Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.
      ]. Because only GSTP1 −313 A/G polymorphism links to enzymatic activity, GSTP1 −313 A/G polymorphism may confer susceptibility to cancers.
      Numerous studies have focused on GSTP1 −313 A/G polymorphism and the risk of various cancers, including lung, breast, colorectal, bladder, pancreatic, thyroid, prostate cancer, and B-cell lymphoma [
      • Huang S.X.
      • Wu F.X.
      • Luo M.
      • et al.
      The glutathione S-transferase P1 341C&gt;T polymorphism and cancer risk: a meta-analysis of 28 case–control studies.
      ]. Up until now, several meta-analyses have been performed on GSTP1 −313 A/G polymorphism and cancers, such as colorectal cancer, prostate cancer, hepatocellular carcinoma, bladder cancer, gastric cancer, lung cancer and breast cancer [
      • Yu Z.
      • Li Z.
      • Cai B.
      • et al.
      Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.
      ,
      • Wang Z.
      • Xue L.
      • Chong T.
      • Li H.
      • Chen H.
      • Wang Z.
      Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.
      ,
      • Ma Y.
      • Wei X.
      • Han G.
      • Xue M.
      • Li G.
      • Li Y.
      Glutathione S-transferase P1 Ile105Val polymorphism contributes to increased risk of gastric cancer in East Asians.
      ,
      • Tan Z.
      • Feng M.
      • Luo Y.
      • et al.
      GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
      ,
      • Zhao Y.
      • Wang Q.
      • Deng X.
      • Shi P.
      • Wang Z.
      Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma.
      ,
      • Zhong H.
      • Feng Y.
      • Zheng G.X.
      • et al.
      A meta-analysis of the association between glutathione S-transferaseP1 gene polymorphism and the risk of adenocarcinomas of lung cancer.
      ,
      • Liu J.J.
      • Liu J.L.
      • Zhang X.
      • Xie L.
      • Zeng J.
      A meta-analysis of the association of glutathione S-transferase P1 gene polymorphism with the susceptibility of breast cancer.
      ]. Previous studies showed that GSTP1 −313 A/G polymorphism contributes to the risk of prostate, bladder and gastric cancer [
      • Yu Z.
      • Li Z.
      • Cai B.
      • et al.
      Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.
      ,
      • Wang Z.
      • Xue L.
      • Chong T.
      • Li H.
      • Chen H.
      • Wang Z.
      Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.
      ,
      • Ma Y.
      • Wei X.
      • Han G.
      • Xue M.
      • Li G.
      • Li Y.
      Glutathione S-transferase P1 Ile105Val polymorphism contributes to increased risk of gastric cancer in East Asians.
      ], but the polymorphism was not considered to be linked with susceptibility to colorectal cancer, hepatocellular carcinoma or lung or breast cancer [
      • Tan Z.
      • Feng M.
      • Luo Y.
      • et al.
      GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
      ,
      • Zhao Y.
      • Wang Q.
      • Deng X.
      • Shi P.
      • Wang Z.
      Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma.
      ,
      • Zhong H.
      • Feng Y.
      • Zheng G.X.
      • et al.
      A meta-analysis of the association between glutathione S-transferaseP1 gene polymorphism and the risk of adenocarcinomas of lung cancer.
      ,
      • Liu J.J.
      • Liu J.L.
      • Zhang X.
      • Xie L.
      • Zeng J.
      A meta-analysis of the association of glutathione S-transferase P1 gene polymorphism with the susceptibility of breast cancer.
      ]. This study was performed to investigate the association between GSTP1 −313 A/G polymorphism and endometriosis, a disease presenting similar biological behaviors to cancers [
      • Giudice L.C.
      • Kao L.C.
      Endometriosis.
      ,
      • Brosens I.
      • Benagiano G.
      • Endometriosis
      a modern syndrome.
      ].
      GSTP1 is a key substance in the biotransformation and inactivation of certain environmental pollutant. Even more, GSTP1 may play an important role in the etiology of malignant disease [
      • Harries L.W.
      • Stubbins M.J.
      • Forman D.
      • Howard G.C.
      • Wolf C.R.
      Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer.
      ]. All this evidence suggests that GSTP1 may be more important than other GST in the pathogenesis of endometriosis [
      • Ertunc D.
      • Aban M.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
      ]. Since the GSTP1 −313A/G polymorphism was identified; several studies have been conducted to evaluate the association of GSTP1 −313 A/G polymorphism with endometriosis risk, but the results remain inconclusive. Ertunc et al. concluded that GSTP1 −313 A/G polymorphism might modulate the risk of endometriosis with significantly decreased risk for GSTP1 val/val and marginally increased risk for GSTP1 ile/ile [
      • Ertunc D.
      • Aban M.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
      ]. Other studies, however, suggested that GSTP1 −313 A/G polymorphism was not associated with endometriosis risk [
      • Wang Y.F.
      • Zong L.L.
      • Mao T.
      • et al.
      Relationship of polymorphisms of AhR-1661G/A with GSTP1-313A/G and susceptibility to endometriosis.
      ,
      • Matsuzaka Y.
      • Kikuti Y.Y.
      • Goya K.
      • et al.
      Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study.
      ,
      • Vichi S.
      • Medda E.
      • Ingelido A.M.
      • et al.
      Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene–environment interaction.
      ,
      • Wu C.H.
      • Guo C.Y.
      • Yang J.G.
      • et al.
      Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population.
      ,
      • Jeon M.J.
      • Choi Y.M.
      • Hong M.A.
      • et al.
      No association between the GSTP1 exon 5 polymorphism and susceptibility to advanced stage endometriosis in the Korean population.
      ,
      • Parveen F.
      • Faridi R.M.
      • Das V.
      • Tripathi G.
      • Agrawal S.
      Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.
      ,
      • Hur S.E.
      • Lee J.Y.
      • Moon H.S.
      • Chung H.W.
      Polymorphisms of the genes encoding the GSTM1 GSTT1 and GSTP1 in Korean women: no association with endometriosis.
      ]. To help explain the diversity of results from different studies, we conducted a meta-analysis to comprehensively explore the GSTP1 −313 A/G polymorphism and endometriosis risk. To the best of our knowledge, this is the first meta-analysis of the assessment for the association between GSTP1 −313 A/G polymorphism and endometriosis risk.
      In the present study, an obvious association was found only in Caucasians under the recessive model (AA vs. GA/GG: OR = 1.28, 95% CI = 1.08–1.53, P = 0.006, Fig. 4 and Table 2). No obvious associations were found in other genetic models in Caucasians, and two studies with small sample size (331 cases and 312 controls) investigated the Caucasians. We concluded that GSTP1 −313 A/G polymorphism may not be associated with endometriosis risk, while the observed increase in risk of endometriosis may be due to small-study bias. Small-study bias in genetic association studies is not a new event when performing meta-analysis. For example, Li et al. published a meta-analysis to evaluate the association between ER-α gene PvuII T/C polymorphisms and endometriosis risk [
      • Li Y.
      • Liu F.
      • Tan S.Q.
      • Wang Y.
      • Li S.W.
      Estrogen receptor-alpha gene PvuII (T/C) and XbaI (A/G) polymorphisms and endometriosis risk: a meta-analysis.
      ]. They concluded that the observed small nominal increase in risk of endometriosis associated with the ER-α PvuII T/C polymorphisms is due to small-study bias, which was similar with our results.
      Obvious heterogeneity among studies was observed in the overall population. Although we found that ethnicity contributed substantial heterogeneity to our results by using the method of meta-regression, some heterogeneity cannot be explained by several possible source of heterogeneity such as ethnicity, sample size and source of controls. In the present meta-analysis, the eligible studies used several genotyping methods including PCR-RFLP, PCR-HRM, TaqMan and Direct Sequencing. All of these genotyping methods are accurate, rapid and commonly used in detecting gene polymorphism of molecular biology experiments. In previous meta-analyses, these genotyping methods were not considered to be the source of heterogeneity. Probably other limitations of included studies may partially contribute to the observed heterogeneity. Hence, we conducted analyses using the random effects model. Another important problem which may have a negative effect on the results is publication bias. In the present study, Funnel plot, and Begg's and Egger's tests were used to assess the publication bias of our included studies. Both the shape of funnel plot and statistical results did not show obvious publication bias. This suggests that the publication bias would not make substantial negative effect on our results and that results of our meta-analysis are relatively stable.
      Endocrine disrupting chemicals (EDCs) have the capacity to interfere with normal signalling systems. EDCs may mimic, block or modulate the synthesis, release, transport and metabolism of natural hormones [
      • Caserta D.
      • Maranghi L.
      • Mantovani A.
      • Marci R.
      • Maranghi F.
      • Moscarini M.
      Impact of endocrine disruptor chemicals in gynaecology.
      ]. Many studies have demonstrated that EDC exposure is a risk factor for women's health and it is closely associated with many kinds of gynecological diseases, including endometriosis [
      • Caserta D.
      • Bordi G.
      • Ciardo F.
      • et al.
      The influence of endocrine disruptors in a selected population of infertile women.
      ,
      • Caserta D.
      • Mantovani A.
      • Marci R.
      • et al.
      Environment and women's reproductive health.
      ,
      • Gentilini D.
      • Perino A.
      • Viganò P.
      • et al.
      Gene expression profiling of peripheral blood mononuclear cells in endometriosis identifies genes altered in non-gynaecologic chronic inflammatory diseases.
      ]. It is a pity that not all of the eligible studies included in our meta-analysis provide information about EDC exposure, so that we could not evaluate the impact of EDC exposure in endometriosis.
      Although comprehensive analysis was conducted to demonstrate the association between GSTP1 −313A/G polymorphism and risk of endometriosis, there are still some limitations should be pointed out. First, only three of the eight included studies used controls that were population-based [
      • Vichi S.
      • Medda E.
      • Ingelido A.M.
      • et al.
      Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene–environment interaction.
      ,
      • Parveen F.
      • Faridi R.M.
      • Das V.
      • Tripathi G.
      • Agrawal S.
      Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.
      ,
      • Ertunc D.
      • Aban M.
      • Tok E.C.
      • Tamer L.
      • Arslan M.
      • Dilek S.
      Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
      ]. Other studies used hospital-based controls, which may not be representative of the general population [
      • Wang Y.F.
      • Zong L.L.
      • Mao T.
      • et al.
      Relationship of polymorphisms of AhR-1661G/A with GSTP1-313A/G and susceptibility to endometriosis.
      ,
      • Matsuzaka Y.
      • Kikuti Y.Y.
      • Goya K.
      • et al.
      Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study.
      ,
      • Wu C.H.
      • Guo C.Y.
      • Yang J.G.
      • et al.
      Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population.
      ,
      • Jeon M.J.
      • Choi Y.M.
      • Hong M.A.
      • et al.
      No association between the GSTP1 exon 5 polymorphism and susceptibility to advanced stage endometriosis in the Korean population.
      ,
      • Hur S.E.
      • Lee J.Y.
      • Moon H.S.
      • Chung H.W.
      Polymorphisms of the genes encoding the GSTM1 GSTT1 and GSTP1 in Korean women: no association with endometriosis.
      ]. Second, the number of studies and the number of subjects included in our meta-analysis were relatively small. Furthermore, there was no original study which investigated African or other ethnicities. Therefore, additional studies with larger sample size and providing detailed information should be conducted to assess the effect of GSTP1 −313A/G polymorphism on endometriosis risk in different ethnicities, especially in Africans. Third, as some studies included in our meta-analysis are based on unadjusted estimates, some risk factors such as age, family history and environment factors might cause confounding bias.
      In spite of the above shortcomings, our meta-analysis also had some advantages. First, a meta-analysis of the association of GSTP1 −313A/G polymorphism on endometriosis risk is statistically more powerful than any single study. Second, a rigorous searching strategy which consisted of computer-assisted and manual searches made the eligible studies as inclusive as possible. Third, the quality of the case–control studies included in our meta-analysis was satisfactory and met our inclusion criteria, which leads to a more reliable result. Furthermore, our meta-analysis was well designed and conducted in the process of literature selection, data extraction and data analysis.
      In conclusion, GSTP1 −313A/G polymorphism may not be associated with endometriosis risk, while the observed increase in risk of endometriosis may be due to small-study bias. Considering the limited sample size and ethnicities included in our meta-analysis, an updated meta-analysis will be urgently needed to confirm our results when further larger and well-designed studies are published.

      Acknowledgements

      This study has been supported by some students in acquisition of data and searching background information relevant to our study. We would like to thank them for their help which led to improvement of this article.

      References

        • Giudice L.C.
        • Kao L.C.
        Endometriosis.
        Lancet. 2004; 364: 1789-1799
        • Halme J.
        • Hammond M.G.
        • Hulka J.F.
        • Raj S.G.
        • Talbert L.M.
        Retrograde menstruation in healthy women and in patients with endometriosis.
        Obstet Gynecol. 1984; 64: 151-154
        • Rier S.E.
        Environmental immune disruption: a comorbidity factor for reproduction?.
        Fertil Steril. 2008; 89: e103-e108
        • Bischoff F.
        • Simpson J.L.
        Genetic basis of endometriosis.
        Ann N Y Acad Sci. 2004; 1034: 284-299
        • Simpson J.L.
        • Elias S.
        • Malinak L.R.
        • Buttram Jr., V.C.
        Heritable aspects of endometriosis. I. Genetic studies.
        Am J Obstet Gynecol. 1980; 137: 327-331
        • Matalliotakis I.M.
        • Arici A.
        • Cakmak H.
        • Goumenou A.G.
        • Koumantakis G.
        • Mahutte N.G.
        Familial aggregation of endometriosis in the Yale Series.
        Arch Gynecol Obstet. 2008; 278: 507-511
        • Autrup H.
        Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.
        Mutat Res. 2000; 464: 65-76
        • Hu X.
        • Benson P.J.
        • Srivastava S.K.
        • et al.
        Glutathione S-transferases of female A/J mouse liver and fore stomach and their different induction by anticarcinogenic organosulfides from garlic.
        Arch Biochem Biophys. 1996; 336: 199-214
        • Hu X.
        • Srivastava S.K.
        • Xia H.
        • Awasthi Y.C.
        • Singh S.V.
        An alpha class mouse glutathione S-transferase with exceptional catalytic efficiency in the conjugation of glutathione with 7b, 8a-dihydroxy-9a, 10a-oxy-7,8,9,10-tetrahydrobenzo[a] pyrene.
        J Biol Chem. 1996; 271: 32684-32688
        • Harries L.W.
        • Stubbins M.J.
        • Forman D.
        • Howard G.C.
        • Wolf C.R.
        Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer.
        Carcinogenesis. 1997; 18: 641-644
        • Wang Y.F.
        • Zong L.L.
        • Mao T.
        • et al.
        Relationship of polymorphisms of AhR-1661G/A with GSTP1-313A/G and susceptibility to endometriosis.
        Zhonghua Fu Chan Ke Za Zhi. 2012; 47 ([Chinese]): 522-525
        • Matsuzaka Y.
        • Kikuti Y.Y.
        • Goya K.
        • et al.
        Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study.
        Environ Health Prev Med. 2012; 17: 512-517
        • Vichi S.
        • Medda E.
        • Ingelido A.M.
        • et al.
        Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene–environment interaction.
        Fertil Steril. 2012; 97: 1143-1151
        • Wu C.H.
        • Guo C.Y.
        • Yang J.G.
        • et al.
        Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population.
        Am J Reprod Immunol. 2012; 67: 160-168
        • Jeon M.J.
        • Choi Y.M.
        • Hong M.A.
        • et al.
        No association between the GSTP1 exon 5 polymorphism and susceptibility to advanced stage endometriosis in the Korean population.
        Am J Reprod Immunol. 2010; 63: 222-226
        • Parveen F.
        • Faridi R.M.
        • Das V.
        • Tripathi G.
        • Agrawal S.
        Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.
        Mol Hum Reprod. 2010; 16: 207-214
        • Ertunc D.
        • Aban M.
        • Tok E.C.
        • Tamer L.
        • Arslan M.
        • Dilek S.
        Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis.
        Hum Reprod. 2005; 20: 2157-2161
        • Hur S.E.
        • Lee J.Y.
        • Moon H.S.
        • Chung H.W.
        Polymorphisms of the genes encoding the GSTM1 GSTT1 and GSTP1 in Korean women: no association with endometriosis.
        Mol Hum Reprod. 2005; 11: 15-19
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Mantel N.
        • Haenszel W.
        Statistical aspects of the analysis of data from retrospective studies of disease.
        J Natl Cancer Inst. 1959; 22: 719-748
        • Higgins J.P.
        • Thompson S.G.
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Munafo M.R.
        • Clark T.G.
        • Flint J.
        Assessing publication bias in genetic association studies: evidence from a recent meta-analysis.
        Psychiatry Res. 2004; 129: 39-44
        • Aban M.
        • Ertunc D.
        • Tok E.C.
        • Tamer L.
        • Arslan M.
        • Dilek S.
        Modulating interaction of glutathione-S-transferase polymorphisms with smoking in endometriosis.
        J Reprod Med. 2007; 52: 715-721
        • Huang S.X.
        • Wu F.X.
        • Luo M.
        • et al.
        The glutathione S-transferase P1 341C&gt;T polymorphism and cancer risk: a meta-analysis of 28 case–control studies.
        PLoS ONE. 2013; 8: e56722
        • Yu Z.
        • Li Z.
        • Cai B.
        • et al.
        Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.
        Tumour Biol. 2013; 34: 1855-1863
        • Wang Z.
        • Xue L.
        • Chong T.
        • Li H.
        • Chen H.
        • Wang Z.
        Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.
        Tumour Biol. 2013; 34: 1651-1657
        • Ma Y.
        • Wei X.
        • Han G.
        • Xue M.
        • Li G.
        • Li Y.
        Glutathione S-transferase P1 Ile105Val polymorphism contributes to increased risk of gastric cancer in East Asians.
        Tumour Biol. 2013; 34: 1737-1742
        • Tan Z.
        • Feng M.
        • Luo Y.
        • et al.
        GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
        Gene. 2013; 527: 275-278
        • Zhao Y.
        • Wang Q.
        • Deng X.
        • Shi P.
        • Wang Z.
        Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma.
        Tumour Biol. 2013; 34: 2121-2126
        • Zhong H.
        • Feng Y.
        • Zheng G.X.
        • et al.
        A meta-analysis of the association between glutathione S-transferaseP1 gene polymorphism and the risk of adenocarcinomas of lung cancer.
        Cancer Biomark. 2013; 13: 29-35
        • Liu J.J.
        • Liu J.L.
        • Zhang X.
        • Xie L.
        • Zeng J.
        A meta-analysis of the association of glutathione S-transferase P1 gene polymorphism with the susceptibility of breast cancer.
        Mol Biol Rep. 2013; 40: 3203-3212
        • Brosens I.
        • Benagiano G.
        • Endometriosis
        a modern syndrome.
        Ind J Med Res. 2011; 133: 581-593
        • Li Y.
        • Liu F.
        • Tan S.Q.
        • Wang Y.
        • Li S.W.
        Estrogen receptor-alpha gene PvuII (T/C) and XbaI (A/G) polymorphisms and endometriosis risk: a meta-analysis.
        Gene. 2012; 508: 41-48
        • Caserta D.
        • Maranghi L.
        • Mantovani A.
        • Marci R.
        • Maranghi F.
        • Moscarini M.
        Impact of endocrine disruptor chemicals in gynaecology.
        Hum Reprod Update. 2008; 14: 59-72
        • Caserta D.
        • Bordi G.
        • Ciardo F.
        • et al.
        The influence of endocrine disruptors in a selected population of infertile women.
        Gynecol Endocrinol. 2013; 29: 444-447
        • Caserta D.
        • Mantovani A.
        • Marci R.
        • et al.
        Environment and women's reproductive health.
        Hum Reprod Update. 2011; 17: 418-433
        • Gentilini D.
        • Perino A.
        • Viganò P.
        • et al.
        Gene expression profiling of peripheral blood mononuclear cells in endometriosis identifies genes altered in non-gynaecologic chronic inflammatory diseases.
        Hum Reprod. 2011; 26: 3109-3117